Fluorofenidone attenuates renal fibrosis by inhibiting lysosomal cathepsin‑mediated NLRP3 inflammasome activation.

Authors:
Zheng L; Mei W; Zhou J; Wei X; Huang Z and 6 more

Journal:
Exp Ther Med

Publication Year: 2024

DOI:
10.3892/etm.2024.12430

PMCID:
PMC10928820

PMID:
38476910

Journal Information

Full Title: Exp Ther Med

Abbreviation: Exp Ther Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Medicine, Research & Experimental

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests The authors declare they have no competing interests."

Evidence found in paper:

"Funding: The present study was supported by the National Natural Science Foundation of China (grant no. 81960678) and the Natural Science Foundation of Jiangxi Province (grant no. 20181BAB215010)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025